amfAR, The Foundation for AIDS Research, one of the world’s leading nonprofit organizations dedicated to the support of AIDS research and HIV prevention, made a huge announcement today:
amfAR, The Foundation for AIDS Research, today announced that it has created a $100 million investment strategy in support of its Countdown to a Cure for AIDS initiative, launched last year with the aim of developing the scientific basis of a cure by 2020. The establishment of the amfAR Institute for HIV Cure Research within a major academic research institution with a grant of $20 million will be the centerpiece of the investment strategy.
“This represents the greatest expansion of amfAR’s grant making in the 30-year history of the Foundation,” said Kevin Robert Frost, amfAR’s Chief Executive Officer. “We’re very excited to be launching this strategy and establishing an institute dedicated exclusively to the pursuit of a cure for HIV. Concentrating the minds and the efforts of leading AIDS cure researchers under one roof will facilitate the rapid sharing of knowledge and ideas and create the kind of synergy needed to accelerate the search for a cure.”
Since 1985, amfAR has invested $415 million in its programs and has awarded grants to more than 3,300 research teams worldwide.